TABLE 3.

Clinical outcomes^‡

	Ready-to-use therapeutic food N = 70	High oleic ready-to-use therapeutic food N = 71	P
Clinical outcomes, n (%)
Recovered	50 (71)	48 (68)	0.72
Remained malnourished	9 (13)	19 (27)
Lost to follow-up	6 (9)	3 (4)
Died	5 (7)	1 (1)
MUAC gain after 4 wk, mm/d#	0.15 ± 0.28	0.22 ± 0.31	0.20
Weight gain after 4 wk, g/kg/d	2.0 ± 2.6	2.8 ± 3.1	0.41
Length gain at study completion, mm/d	0.13 ± 0.36	0.22 ± 0.34	0.22
Weight-for-height at recovery, z-score	−0.60 ± 1.0	−0.15 ± 1.3	0.02
Plasma PL fatty acid (%,w/w) after 4 wk	N=35	N=43
Docosahexaenoic acid (DHA)	2.4 ± 1.1	3.0 ± 1.5	0.04
Eicosapentaenoic acid (EPA)	0.5 ± 0.6	1.1 ± 0.8	< 0.001
α-linolenic acid (ALA)	0.7 ± 1.1	0.8 ± 0.8	0.53
Linoleic acid (LA)	17.3 ± 6.5	16.3 ± 5.7	0.43
Arachidonic acid	7.6 ± 3.7	5.6 ± 3.2	< 0.01

^‡Values are means ± SD or n (%)

^#MUAC, mid-upper arm circumference